Báez Indira Rojo, Castro Daniel Omar Rivera, Gutiérrez Sarahí Salas, López Edgar Dehesa, Lemarroy Adriana Aguilar, Suarez Luis Felipe Jave, Ureta Hipólito Castillo, Montoya Edith Hilario Torres, Andalón Vicente Olimón
Department of Immunogenetics, Facultad de Biología, Universidad Autónoma de Sinaloa, Culiacán, Sinaloa, Mexico.
Facultad de Biología, Universidad Autónoma de Sinaloa, Culiacán, Sinaloa, Mexico.
Sao Paulo Med J. 2020 Mar;138(2):133-139. doi: 10.1590/1516-3180.2019.0304.r2.09122019. Epub 2020 Jun 1.
Diabetic nephropathy is a common complication of chronic kidney disease (CKD). -Inflammation in the kidneys is crucial for promoting development and progression of this complication. Wnt member 5a (Wnt5a) and secreted frizzled-related protein 5 (Sfrp5) are proinflammatory proteins associated with insulin resistance and chronic low-grade adipose tissue inflammation.
To determine the correlation between serum Sfrp5 and Wnt5a concentrations and glomerular filtration rate in patients with type 2 diabetes mellitus and CKD.
Cross-sectional, comparative and observational study in the Department of Endocrinology, Civil Hospital, Culiacán, Sinaloa, Mexico.
Eighty individuals with chronic kidney disease were recruited. Their serum Sfrp5 and Wnt5a concentrations were quantified using the enzyme-linked immunosorbent assay (ELISA) test. The statistical analysis consisted of the Mann-Whitney U test for independent samples and Spearman correlation, with statistical significance of P < 0.05.
Serum Sfrp5 concentration continually increased through the stages of CKD progression, whereas serum Wnt5a concentration presented its highest levels in stage 3 CKD. Negative correlations between estimated glomerular filtration rate (eGFR) and serum concentrations of Sfrp5 (r = -0434, P = 0.001) and Wnt5a (r = -0481, P = 0.001) were found.
There were negative correlations between serum Sfrp5 and Wnt5a concentrations and eGFR at each stage of CKD, with higher levels in female patients. This phenomenon suggests that Sfrp5 and Wnt5a might be involved in development and evolution towards end-stage renal disease.
糖尿病肾病是慢性肾脏病(CKD)的常见并发症。肾脏炎症对于促进该并发症的发生和发展至关重要。Wnt成员5a(Wnt5a)和分泌型卷曲相关蛋白5(Sfrp5)是与胰岛素抵抗和慢性低度脂肪组织炎症相关的促炎蛋白。
确定2型糖尿病合并CKD患者血清Sfrp5和Wnt5a浓度与肾小球滤过率之间的相关性。
在墨西哥锡那罗亚州库利亚坎市民医院内分泌科进行的横断面、比较性观察研究。
招募80例慢性肾脏病患者。采用酶联免疫吸附测定(ELISA)试验对其血清Sfrp5和Wnt5a浓度进行定量。统计分析包括独立样本的曼-惠特尼U检验和Spearman相关性分析,P<0.05具有统计学意义。
血清Sfrp5浓度在CKD进展各阶段持续升高,而血清Wnt5a浓度在CKD 3期时达到最高水平。发现估算肾小球滤过率(eGFR)与血清Sfrp5浓度(r=-0.434,P=0.001)和Wnt5a浓度(r=-0.481,P=0.001)之间呈负相关。
在CKD各阶段,血清Sfrp5和Wnt5a浓度与eGFR之间均呈负相关,女性患者水平更高。这一现象提示Sfrp5和Wnt5a可能参与终末期肾病的发生和发展。